MoonLake Immunotherapeutics (MLTX) Prepaid Assets (2020 - 2026)
MoonLake Immunotherapeutics (MLTX) posted quarterly Prepaid Assets of $33.0 million for Q1 2026, up 42.39% year-over-year from $23.1 million in Q1 2025, and up 44.19% quarter-over-quarter from $22.9 million in Q4 2025.
MoonLake Immunotherapeutics (MLTX) Prepaid Assets (2020 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $33.0 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 42.39% year-over-year to $33.0 million; the TTM figure through Mar 2026 stood at $33.0 million (up 42.39% YoY), while the FY2025 annual figure was $22.9 million, down 2.4% from the prior year.
- Prepaid Assets for Q1 2026 stood at $33.0 million, up from $22.9 million in the prior quarter.
- The five-year high for Prepaid Assets was $33.0 million in Q1 2026, with the low at $135916.0 in Q1 2022.
- The 5-year median for Prepaid Assets is $5.1 million (2022), against an average of $12.9 million.
- Peak annual rise in Prepaid Assets reached 2415.82% in 2022, while the deepest fall reached 53.07% in 2022.
- MoonLake Immunotherapeutics' Prepaid Assets stood at $4.2 million in 2022, then slumped by 49.7% to $2.1 million in 2023, then surged by 1013.97% to $23.4 million in 2024, then fell by 2.4% to $22.9 million in 2025, then surged by 44.19% to $33.0 million in 2026.
- Business Quant data shows MLTX's Prepaid Assets at $33.0 million in Q1 2026, $22.9 million in Q4 2025, and $26.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | MoonLake Immunotherapeutics | 1.40 Bn | 864.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.45 Mn |
| Mar 31, 2026 | 32.96 Mn |
| Dec 31, 2025 | 22.86 Mn |
| Sep 30, 2025 | 26.71 Mn |
| Jun 30, 2025 | 26.99 Mn |
| Mar 31, 2025 | 23.15 Mn |
| Dec 31, 2024 | 23.42 Mn |
| Sep 30, 2024 | 15.98 Mn |
| Jun 30, 2024 | 15.41 Mn |
| Mar 31, 2024 | 5.04 Mn |
| Dec 31, 2023 | 2.10 Mn |
| Sep 30, 2023 | 3.31 Mn |
| Jun 30, 2023 | 3.96 Mn |
| Mar 31, 2023 | 3.08 Mn |
| Dec 31, 2022 | 4.18 Mn |
| Sep 30, 2022 | 4.48 Mn |
| Jun 30, 2022 | 5.11 Mn |
| Mar 31, 2022 | 135,916.00 |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | 178,041.00 |